1.3510.00% ( 0.000 )
Delay Closed: Nov 13, 16:00:00 (EDT)Valuation
Current ValuationThe current P/E ratio is -22.66, within the reasonable range, cheaper than 26.82% of the time in the past 1 years, and the industry ranks 42/53, the industry Median -0.09.
-22.66xP/E
$1.35Stock price
$-0.06Earnings per share
-22.66xP/E
Stock price$1.35Earnings per share$-0.06
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- -28.38x
- Typical range
- -33.77x–-21.64x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0285684112
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
COTYUSCoty | -6.18x | 128.02% | $3.56B |
EPCUSEdgewell Personal Care | -24.32x | 220.83% | $1.26B |
USNAUSUSANA Health Sciences | -11.54x | 255.17% | $244.63M |
NUSUSNu Skin | -0.84x | 257.23% | $196.17M |
YSGUSYatsen | -6.05x | 34.19% | $181.97M |
MEDUSMedifast | -3.55x | 19.41% | $145.01M |
GLASUSGlass House Brands | -1.87x | -- | $119.69M |
SKINUSSkinHealth | -5.80x | 33.28% | $106.13M |
MLKMFUSWALDENCAST PLC | -0.57x | -- | $95.50M |
UPXIUSUpexi | -0.20x | -- | $44.76M |
BHSTUSBioHarvest Sciences | -2.87x | 6.25% | $34.12M |
ZIVOUSZivo Bioscience | -2.82x | -- | $23.91M |
HYEXUSHealthy Extracts Inc. | -22.66x | -- | $19.92M |
DQWSUSDSwiss, Inc. | -70.67x | -- | $17.38M |
DSYUSBig Tree Cloud | -- | -- | $13.45M |
MTEXUSMannatech | -1.64x | -- | $12.16M |
GLUCUSGlucose Health, Inc. | -- | -- | $8.70M |
CABRUSCaring Brands | -0.84x | -- | $8.34M |
BNKKUSBonk | -0.09x | -- | $7.30M |
NHTCUSNatural Health Trend | -4.44x | -- | $6.33M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
